ATE181925T1 - Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau - Google Patents
Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbauInfo
- Publication number
- ATE181925T1 ATE181925T1 AT92914209T AT92914209T ATE181925T1 AT E181925 T1 ATE181925 T1 AT E181925T1 AT 92914209 T AT92914209 T AT 92914209T AT 92914209 T AT92914209 T AT 92914209T AT E181925 T1 ATE181925 T1 AT E181925T1
- Authority
- AT
- Austria
- Prior art keywords
- cathepsin
- connective tissue
- elastase
- inhibitors
- tissue degradation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Dental Preparations (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Vehicle Body Suspensions (AREA)
- Transceivers (AREA)
- Mobile Radio Communication Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70449991A | 1991-05-23 | 1991-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181925T1 true ATE181925T1 (de) | 1999-07-15 |
Family
ID=24829789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92914209T ATE181925T1 (de) | 1991-05-23 | 1992-04-21 | Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5510333A (de) |
| EP (1) | EP0587799B1 (de) |
| JP (1) | JP3442075B2 (de) |
| AT (1) | ATE181925T1 (de) |
| AU (1) | AU655301B2 (de) |
| DE (1) | DE69229552T2 (de) |
| DK (1) | DK0587799T3 (de) |
| ES (1) | ES2136091T3 (de) |
| FI (1) | FI935172A0 (de) |
| GR (1) | GR3031005T3 (de) |
| HU (1) | HU217612B (de) |
| IL (1) | IL101925A (de) |
| NO (1) | NO934218D0 (de) |
| NZ (1) | NZ242807A (de) |
| PT (1) | PT100517B (de) |
| WO (1) | WO1992020357A1 (de) |
| ZA (1) | ZA923602B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5714470A (en) * | 1991-08-22 | 1998-02-03 | Merrell Pharmaceuticals, Inc. | Orally-active elastase inhibitors |
| WO1993021221A1 (en) * | 1992-04-10 | 1993-10-28 | Abbott Laboratories | Pulmonary surfactant protein fragments |
| EP0644892A1 (de) * | 1992-06-12 | 1995-03-29 | Pfizer Inc. | Inhibitoren für Angiotensin I-Chymasen inklusive der menschlichen Herzchymase |
| FI964749A0 (fi) * | 1994-06-02 | 1996-11-28 | Merrell Pharma Inc | Asyloituja enolijohdannaisia elastaasi-inhibiittoreiden lääkkeen esiasteina |
| JP3721538B2 (ja) * | 1994-06-02 | 2005-11-30 | メレル ファーマスーティカルズ インコーポレイテッド | エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法 |
| US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
| US5872101A (en) * | 1995-01-06 | 1999-02-16 | Sibia Neurosciences, Inc. | Methods of treating neurodegenerative disorders using protease inhibitors |
| US5693515A (en) * | 1995-04-28 | 1997-12-02 | Arris Pharmaceutical Corporation | Metal complexed serine protease inhibitors |
| DE19543750C2 (de) * | 1995-11-24 | 1997-10-23 | Crinos Industria Farmaco | Cathepsin G inhibierende Aptamere |
| US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
| US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
| DE69726426T3 (de) * | 1996-04-22 | 2009-09-10 | Massachusetts Institute Of Technology, Cambridge | Unterdrückung von immunantwort durch hemmung von cathepsin s |
| JP2002047256A (ja) * | 2000-07-26 | 2002-02-12 | Kanegafuchi Chem Ind Co Ltd | α−アミノ−α´，α´，α´−トリハロケトン誘導体、α−アミノ−α´，α´，α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法 |
| WO2008054144A1 (en) * | 2006-11-03 | 2008-05-08 | Amorepacific Corporation | Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials |
| US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
| BR112022004861A2 (pt) | 2019-09-17 | 2022-06-07 | Univ Duke | Alvelestat para uso no tratamento de rejeição de transplante, síndrome de bronquiolite obliterante e doença de transplante versus hospedeiro |
| US20230190723A1 (en) | 2020-04-16 | 2023-06-22 | Mereo Biopharma 4 Limited | Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency |
| AU2021289665A1 (en) | 2020-06-10 | 2022-12-15 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
| IL309732A (en) | 2021-07-09 | 2024-02-01 | Aligos Therapeutics Inc | Antiviral compounds |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
| AU2022373971A1 (en) | 2021-10-20 | 2024-04-04 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
| WO2024254398A2 (en) * | 2023-06-07 | 2024-12-12 | Redd Pharmaceuticals, Inc. | Modulation of neutrophil activation and neutrophil extracellular trap (net) formation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3230275A1 (de) * | 1982-08-14 | 1984-02-16 | Bayer Ag, 5090 Leverkusen | Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel |
| DE3324534A1 (de) * | 1983-07-07 | 1985-01-17 | Ciba-Geigy Ag, Basel | Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel |
| US4629724A (en) * | 1984-12-03 | 1986-12-16 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitors |
| US4643991A (en) * | 1984-12-18 | 1987-02-17 | The University Of Kentucky Research Foundation | Peptide elastase inhibitors and methods |
| US5055450A (en) * | 1985-01-22 | 1991-10-08 | Ici Americas Inc. | Peptide derivatives |
| GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
| AU600226B2 (en) * | 1985-02-04 | 1990-08-09 | Merrell Pharmaceuticals Inc. | Novel peptidase inhibitors |
| DE3683541D1 (de) * | 1985-06-07 | 1992-03-05 | Ici America Inc | Selektionierte difluorverbindungen. |
| GB8613703D0 (en) * | 1986-06-05 | 1986-07-09 | Ici America Inc | Difluoro peptide compounds |
| NZ223148A (en) * | 1987-01-16 | 1989-10-27 | Merrell Dow Pharma | Peptide derivatives having peptidase inhibition activity |
| EP0307662A3 (de) * | 1987-08-24 | 1990-07-25 | Kabushiki Kaisha Vitamin Kenkyusyo | Enkephalin-Analoge |
| EP0356595A1 (de) * | 1988-09-01 | 1990-03-07 | Merrell Dow Pharmaceuticals Inc. | Peptidase-Hemmer |
| ZA897514B (en) * | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
| CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
| DE3938971A1 (de) * | 1989-11-24 | 1991-05-29 | Biotechnolog Forschung Gmbh | Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat |
-
1992
- 1992-04-21 FI FI935172A patent/FI935172A0/fi unknown
- 1992-04-21 DE DE69229552T patent/DE69229552T2/de not_active Expired - Fee Related
- 1992-04-21 JP JP50004493A patent/JP3442075B2/ja not_active Expired - Fee Related
- 1992-04-21 ES ES92914209T patent/ES2136091T3/es not_active Expired - Lifetime
- 1992-04-21 AU AU21841/92A patent/AU655301B2/en not_active Ceased
- 1992-04-21 WO PCT/US1992/003288 patent/WO1992020357A1/en not_active Ceased
- 1992-04-21 AT AT92914209T patent/ATE181925T1/de not_active IP Right Cessation
- 1992-04-21 DK DK92914209T patent/DK0587799T3/da active
- 1992-04-21 EP EP92914209A patent/EP0587799B1/de not_active Expired - Lifetime
- 1992-04-21 HU HU9303314A patent/HU217612B/hu not_active IP Right Cessation
- 1992-05-18 ZA ZA923602A patent/ZA923602B/xx unknown
- 1992-05-19 IL IL10192592A patent/IL101925A/en not_active IP Right Cessation
- 1992-05-20 NZ NZ24280792A patent/NZ242807A/en unknown
- 1992-05-22 PT PT100517A patent/PT100517B/pt not_active IP Right Cessation
-
1993
- 1993-11-22 NO NO934218A patent/NO934218D0/no not_active Application Discontinuation
-
1995
- 1995-06-05 US US08/462,456 patent/US5510333A/en not_active Expired - Fee Related
-
1999
- 1999-08-18 GR GR990402083T patent/GR3031005T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69229552T2 (de) | 1999-12-23 |
| DE69229552D1 (de) | 1999-08-12 |
| NO934218L (no) | 1993-11-22 |
| ES2136091T3 (es) | 1999-11-16 |
| NZ242807A (en) | 1994-07-26 |
| FI935172L (fi) | 1993-11-22 |
| GR3031005T3 (en) | 1999-12-31 |
| IL101925A (en) | 1996-03-31 |
| IL101925A0 (en) | 1992-12-30 |
| EP0587799A1 (de) | 1994-03-23 |
| PT100517A (pt) | 1993-09-30 |
| FI935172A7 (fi) | 1993-11-22 |
| PT100517B (pt) | 1999-06-30 |
| JPH06508355A (ja) | 1994-09-22 |
| WO1992020357A1 (en) | 1992-11-26 |
| US5510333A (en) | 1996-04-23 |
| HUT65140A (en) | 1994-04-28 |
| JP3442075B2 (ja) | 2003-09-02 |
| AU655301B2 (en) | 1994-12-15 |
| HU217612B (hu) | 2000-03-28 |
| FI935172A0 (fi) | 1993-11-22 |
| DK0587799T3 (da) | 1999-11-22 |
| AU2184192A (en) | 1992-12-30 |
| EP0587799B1 (de) | 1999-07-07 |
| EP0587799A4 (de) | 1995-06-14 |
| ZA923602B (en) | 1993-02-24 |
| NO934218D0 (no) | 1993-11-22 |
| HU9303314D0 (en) | 1994-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE181925T1 (de) | Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau | |
| ATE193304T1 (de) | Inhibitoren der menschlichen neutrophilenelastase | |
| ATE348096T1 (de) | C-terminal modifizierte oxamyl dipeptide als inhibitorse von der ice/ced-3 familie von cystein proteasen | |
| ATE416761T1 (de) | Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund | |
| DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
| DK0529568T3 (da) | Nye oralt aktive elastaseinhibitorer | |
| DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
| FI943233A7 (fi) | Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos | |
| DK1029921T3 (da) | Serpinresistent t-PA, mutanter, gener | |
| BG99177A (bg) | Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза | |
| FI943234A7 (fi) | Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos | |
| FI943231L (fi) | Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnoksia | |
| ATE196083T1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| DK0804465T3 (da) | Nye elastaseinhibitorer | |
| TR200001026T2 (tr) | Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri. | |
| DE69409961D1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| CA2109516A1 (en) | Inhibitors of cathepsin g and elastase for preventing connective tissue degradation | |
| FI972673A7 (fi) | 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |